Printer Friendly

Browse Meningococcal vaccines topic

Dosage and administration subtopic

Articles

1-34 out of 34 article(s)
Title Author Type Date Words
Meningitis and Teens: What You Need to Know. Friedland, Leonard Sep 1, 2018 588
ACIP weighs in on meningococcal B vaccines. Campos-Outcalt, Doug Dec 1, 2015 1398
New meningitis vaccine to be introduced for school leavers. Brief article Sep 1, 2015 153
Babies to receive men B vaccine. Brief article Aug 1, 2015 165
Meningococcal vaccine for infants? With the incidence of meningococcal disease declining in all age groups, ACIP is weighing the need for vaccination in children <2 years. Campos-Outcalt, Doug Aug 1, 2012 1187
Updated recommendations for use of meningococcal conjugate vaccines - Advisory Committee on Immunization Practices (ACIP), 2010. Jan 28, 2011 3381
ACIP update: 2 new recommendations for meningococcal vaccine: you now need to give previously vaccinated teens a booster dose at age 16 and protect high- risk patients with a 2-dose primary series. Campos-Outcalt, Doug Dec 1, 2010 1498
Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease. Clinical report Sep 25, 2009 864
No tie seen Between MCV4, Guillain-Barre syndrome. Tucker, Miriam E. Mar 15, 2009 437
Routine Menactra nixed for younger children. Tucker, Miriam E. Mar 15, 2008 607
Emergence of fluoroquinolone-resistant Neisseria meningitidis--Minnesota and North Dakota, 2007-2008. Rainbow, J.; Boxrud, D.; Glennen, A.; Danila, R.; Juni, B.; Mariotti, J.; Lynfield, R.; Baird, J.; K Clinical report Feb 22, 2008 1891
Recommended immunization schedules for persons aged 0-18 years--United States, 2008. Table Jan 11, 2008 4018
GBS is precaution for Menactra administration. Tanzola, Melinda Brief article Nov 15, 2007 288
MCV4 advocated for at-risk kids aged 2-10 years. Tanzola, Melinda Nov 15, 2007 444
MCV4 advocated for at-risk kids aged 2-10. Tanzola, Melinda Nov 1, 2007 914
ACIP: Menactra for all kids aged 11-18. Splete, Heidi Jul 15, 2007 701
Vaccine mix-up risk rises with greater product availability. Wendling, Patrice May 1, 2007 677
Guillain-Barre risk from Menactra under review. Tucker, Miriam E. Apr 1, 2007 601
Mistaken Menactra still protective. Brief article Dec 15, 2006 209
The preteen visit: an opportunity for prevention: updated vaccine guidelines for different age groups; USPSTF recommendations for other interventions. Campos-Outcalt, Doug Dec 1, 2006 1335
Guillain-Barre syndrome-MCV4 link still unclear. Tucker, Miriam E. Nov 1, 2006 803
Menactra protects despite error. Splete, Heidi Brief article Nov 1, 2006 265
Target teens for the meningitis vaccine: the majority of cases--most often caused by serogroups C and Y--could be prevented. Mahoney, Diana Feb 1, 2006 631
Two new vaccines in 2006. Jan 1, 2006 2716
Pneumococcal meningitis dips in younger, not older, patients. Boschert, Sherry Dec 1, 2005 414
Immunization efforts focus on adolescents: teenagers increasingly are being recognized as important reservoirs for certain infectious diseases. Mahoney, Diana Dec 1, 2005 1642
Guillain-Barre cases prompt vaccine alert. Worcester, Sharon Nov 1, 2005 412
Meningococcal vaccine: new product, new recommendations. Campos-Outcalt, Doug Apr 1, 2005 1152
New conjugate meningococcal vaccine recommended by ACIP for younger teens. Tucker, Miriam E. Mar 15, 2005 557
Meningococcal vaccination keyed to preteen visit. Tucker, Miriam E. Mar 15, 2005 606
Menactra advised for preadolescents. Tucker, Miriam E. Mar 1, 2005 809
Immunisation programme extended to high-risk babies. Brief Article Feb 1, 2005 169
ACIP sends Menactra guidelines back for revision. Walsh, Nancy Nov 15, 2004 792
Meningococcal vaccine gets advisory panel nod: unanimous endorsement for Menactra. Tucker, Miriam E. Oct 1, 2004 617

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters